Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer
NCT01612871Phase 4Completed
- Sponsor
- Institut Claudius Regaud
- Start
- Jun 2012
- Primary completion
- Jan 2016
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of tamoxifen, letrozole, anastrozole, exemestane in breast cancer, sponsored by Institut Claudius Regaud. Started Jun 2012; status: completed.
02
Drugs
tamoxifenletrozoleanastrozoleexemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01612871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01612871.